جمعه 8 اسفند 1404

اطلاعات کوهورت

آزمایشگاه جامع تحقیقات

آخرین بروزرسانی : دو شنبه 23 بهمن 1402   

 

 

 

 

         عنوان مطالعه: بررسی عوامل خطر بيماری های عروق کرونر در جمعيت 15 تا 80 ساله شهر کرمان

 

 

 

نام و نام خانوادگی محقق اصلی: دکتر حميد نجفی پور

 

تلفن ثابت: 32264071-034

 

پست الکترونيکی: najafipourh@yahoo.co.uk

 

آدرس: کرمان،چهارراه طهماسب آباد،ابتدای بلوار جهاد،ابتدای خيابان ابن سینا،معاونت تحقيقات و فناوری، پژوهشکده نوروفارماکولوژی، مرکز تحقیقات فیزیولوژی

 

سال شروع مطالعه: 1388

 

 

مشخصات فازهای مطالعه:

 فاز 1- محدوده سنی 15 تا 75 سال، حجم نمونه 6000 نفر

مهر 1388 تا مهر 1390

فاز 2- محدوده سنی 15 تا 80 سال، حجم نمونه 10000 نفر

مهر 1393 تا مهر 1397

فاز 3- محدوده سنی 15 تا 85 سال، حجم نمونه مورد انتظار 10000 نفر

آبان 1398 تا اسفندماه 1402 (9200 نفر)

 نمونه گیری تصادفی از منازل 250 کد پستی شهر در فاز اول - از 420 کد پستی در فازهای دوم و سوم

 

حيطه فعاليت مطالعه: عوامل خطر بيماريهای عروق کرونر قلب

 

جمعيت تحت پوشش مطالعه: زنان و مردان 15 تا 85 ساله شهر کرمان

 

منتطقه تحت پوشش مطالعه: مناطق 4گانه شهری کرمان

 

مشخصات بيوبانک: ذخيره نمونه های سرم وDNA شرکت کنندگان

 

بروندادهای علمی منتج از مطالعه(تعداد و عناوين مقالات،گايدلاين ها،پايان نامه ها و کتب و...):

 

فاز اول   43 مقاله

 

عناوین مقالات:

 

  1. Mohammadi TM, Sabouri A, Sabouri S, Najafipour H. Anxiety, depression, and oral health: A population-based study in Southeast of Iran. Dent Res J 2019;16:139-44.

 

  1. Gholamhossenian A, Shahouzehi B, Shokoohi M, Najafipour H. B12 and Folate Concentrations in Opium Addicts Compared to Healthy Subjects: A Case Control Study from Kerman Coronary Artery Disease Risk Study. Addict Health 2018; 10(3).

 

  1. Rezapour M, Shahesmaeili A, Hossinzadeh A, Zahedi R, Najafipour H, Gozashti MH. Comparison of lipid ratios to identify metabolic syndrome.Arch Iran Med. 2018;21(12):572–577.

 

 

  1. Najafipour H, Afshari M, Rostamzadeh F. Prevalence of Multiple Coronary Artery Disease Risk Factors in Kerman: A Population-Based Study in Southeast Iran. Iran J Med Sci. 2018 ;43(2):140-149.

 

 

 

  1. Mahmoodi M.R ,Najafipour H ,Mohsenpour M.A , Amiri M. The relationship between food insecurity with cardiovascular risk markers and metabolic syndrome components in patients with diabetes: A population‑based study from Kerman coronary artery disease risk study. Journal of Research in Medical Sciences 2017; 31(22):118

 

  1.  Mohammadi TM, Hasheminejad N, Salari HR, Rostamizadeh MR, Najafipour H. Association between tooth loss and opium addiction: Results of a community-based study on 5900 adult individuals in South East of Iran in 2015. J Int Soc Prevent Communit Dent 2017;7:186-90.

 

  1.  Saber A  , Naghibzadeh Tahami A ,Najafipour  H, Azmandian J. Assessment of Prevalence of Chronic Kidney Disease and Its Predisposing Factors in Kerman City. Nephrourol Mon 2017; 9(2):e41794.

 

  1. Mojgan Sanjari,  Zohreh Safi, Khatereh Mohammadi Tahroodi .HYPERTHYROIDISM AND HYPERPROLACTINEMIA: IS THERE ANY ASSOCIATION?. Endocrine Practice 2016;22(12):1377-1382

 

  1. Najafipour H, Moazenzadeh M, Afshari M,  Nasri HR, Khaksari M,  Forood A, Sheikzadeh K, Mirzazadeh A. Prevalence of  Low Physical Activity and its relationship with Other Cardiovascular Risk Factors: a Community-based Study (KERCADRS). Asian ARYA Atheroscler 2016;12(5):212-219.

 

 

  1. Najafipour H, Beik Ahmad. The Impact of Opium Consumption on Blood Glucose, Serum Lipids and Blood Pressure, and Related Mechanisms(A Review).Front Physiol 2016;7:436.

 

  1. Najafipour H, Shokohi M,Yousefzadeh G, SarvarAzimzadeh B, MoshtaghiKashanian G, Bagheri MM, Mirzazadeh A. Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS).J Diabetes& Metabolic disorders 2016;15:49.

 

 

  1. Najafipour H, Askaripour M, Hosseinzadeh A, Sadeghi Z. The Prevalence of Coronary Artery Diseases Risk Factors in Four Regions of Kerman City. JKUMS 2016;23(4):406-420. [Article in Persian]

 

  1. Najafipour H, Banivaheb G, Sabahi A, Naderi N,Nasirian M, Mirzazade A. Prevalence of anxiety and depression symptoms and their relationship with other coronary artery disease risk factors: A population-basedstudy on 5900 residents in Southeast Iran.Asian Journal of psychiatry 2016;20(2016):55–60.

 

 

  1. Foroozanfar Z, Ebrahimi H, Khanjani N, Bahrampour A, Najafipour H . Prevalence of Carpal Tunnel Syndrome in Diabetic Patients with and without Metabolic Syndrome.         J Endoc Diabetes Mellitus 2016;4(1).

 

  1. Yousefzadeh G, Gozashti MH, Najafipour H, GholamhosseinianNajar A, Bahramnejad A, Shokouhi M. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus. Diabetes&Metabolic Syndrome: Clinical Research&Reviews 10S (2016);S52–S55.

 

 

  1. Salimzadeh H, Najafipour H, Mirzaiepour F, Navadeh S, Shadkam-Farrokhi M, Mirzazadeh A. Prevalence of Active and Passive Smoking among Adult Population: Findings of a Population-Based Survey in Kerman,Iran (KERCADRS). Addict Health 2016;8(1).

 

  1. Najafipour H, Yousefzadeh Gh, Forood A, Karamouzian M, Shadkam M, Mirzazadeh A. Overweight and obesity prevalence and its predictors in a general population: A community-based study in Kerman, Iran (Kerman coronary artery diseases risk factors studies). ARYA Atheroscler 2016;12(1):18-27.

 

  1. Najafipour H, YeganehHajahmadi M, Nasri HR, Sadeghi Z. Effect of opium addiction and six other risk factors on hypertension: a population-based study in 5900 adults in Kerman. Iran JPP 2015;1(4):156-165.[in Persian].

 

 

  1. Masoomi M, Azdaki N, Shahouzehi B. Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals. Addict Health 2015;7(3-4).

 

  1. Safavi F, Yousefzadeh G, Shokoohi M, Safavi S, Najafipour H, ShadkamFarokhi M.Prevalence of Metabolic Syndrome in Patients with Periodontal Disease. Journal of Kerman University of Medical Sciences 2015;22(3):229-239.[in Persian].

 

 

  1. Najafipour H, Sabahi A, Mirrashidi F, Afshari M, Haghdoost AA. Sleep Status and its relationship with other Coronary Artery Diseases Risk Factors: Findings of a Community-based Study in South East of Iran. Journal of sleep disorders and therapy 2015;4(3):6 pages.

 

  1. Foroozanfar Z, Najafipour H, Khanjani N, Bahrampour A, Ebrahimi H. The prevalence of metabolic syndrome according to different criteria and its associated factors in type 2 diabetic patients in Kerman, Iran.Iran J Med Sciences 2015;40(6):522-525.

 

 

  1. Tajadini H, Divsalar K, Mehrabani M, Haghdoost A.A, Esmaeili Z, Shadkam M. The frequency of using herbal medicine among patients with hypertension in Kerman, Iran, 2012-2013. Journal of Evidence-Based Complementary and Alternative Medicine       2015; April, pages 1-4.

 

  1. Najafipour H, Masoomi M, Shahesmaeili A, Haghdoost AA, Afshari M, Nasri H Reza, Kahnooji M, Etemad K, Mirzazadeh A. Effect of opium consumption on coronary artery disease risk factors and oral health: Results of KERCADRS population-based survey on 5900 subjects aged 15-75 years. Int J Preventive Med 2015;6:42:7 pages.

 

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H, Shadkamfarokhi M. Applying Framingham Risk Score for Prediction of Metabolic Syndrome: the Kerman Coronary Artery Disease Risk study (KERCADRS). ARYA Atherosclerosis 2015;11(3):1-7.

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H, Eslami M, Salehi F. Association between opium use and metabolic syndrome in an urban population in southern Iran:  Results of the Kerman Coronary Artery Disease Risk factor Study (KERCADRS). Arya Atherosclerosis 2015,11(1):7 pages.

 

 

  1. Yousefzadeh G, Shokoohi M, Najafipour H. Inadequate control of diabetes and metabolic indices among diabetic patients: a population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). International Journal of Health Policy and Management (IJHPM) 2015;4(5):271-277.

 

  1. Najafipour H, Sanjari M, Shokoohi M, Haghdoost AA, Afshari M, Shadkam M, Etemad K, Mirzazadeh A. Epidemiology of Diabetes Mellitus, Pre-Diabetes, Undiagnosed and Uncontrolled Diabetes and Its Predictors in General Population Aged 15 to 75 Years: A Community-based Study (KERCADRS) in Southeastern Iran. J Diabetes 2015 Sep;7(5):613-21.

 

 

  1. Gozashti MH, Shafiei M, EsmaeilianS, Najafipour H, MashroutehM. The prevalence of latent autoimmune diabetes in adults and its correlates in patients with type 2 diabetes in Kerman, Iran[2011]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2015 Apr-Jun;9(2):104-7.

 

  1. Yousefzadeh Gh, SheiknAkhavan M. Age and gender differences in the clustering of metabolic syndrome combinations: a prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetes&Metabolic Syndrome: Clinical Research & Reviews 2015;9(4):367-372.

 

 

  1. Aram-Ahmaddi M, Bahrampour A, Najafipour H. Predicting Type Two Diabetes and Determination of Effectiveness of Risk Factors Applying Logistic Regression Model. Journal of Kerman University of Medical Sciences 2014;21(2):103-113. [in Persian].

 

  1. Rahimi N, Gozashti M.H, Marefati H, Rahnama K, Aghaei I, Moosazadeh M. Prevalence of Cardiovascular Risk Factors in Diabetic Patients and its Relationship with Opium Consumption. Journal of Guilan University of medical Sciences 2014;22(88):49-57.[in Persian].

 

 

  1. Najafipour H, Nasri HR, Afshari M, Moazenzadeh M, Shokoohi M, Forood A, Koorosh E, Sadeghi B, Mirzazadeh A. Hypertension, Pre-Hypertension, Undiagnosed and Uncontrolled Hypertension and its Predictors in General Population Aged 15 to 75 Years: A Community-based Study in Southeastern Iran. International Journal of Public Health 2014;59(6):999-1009.

 

  1. Gozashti MH, Fedaei N, Shojaei M, Najafipour H. Determination of most suitable cut off point of waist circumference for diagnosis of metabolic syndrome in Kerman.Diabetes& Metabolic Syndrome:Clinical Research&Reviews 2014;8(1):8-12.

 

 

  1. Hayatbakhsh M, Zahedi MJ, Darvish-moghaddam S, Seyedmirzaie SM, Najafipour H, Haghdoust AA, Mahmoudi A.The Prevalence of Irritable Bowel Syndrome, and its Clinical Symptoms and Related Factorsamong the Adult Population of Kerman,Iran. Journal of Kerman University of Medical Sciences 2013;20(4):331-342.[in Persian]

 

  1. Yousefzadeh Gh, Mahdavi-Jafari F, Shokoohi M, Najafipour H, HaghdoostAA, ModaresNejad V.  Modulation of coronary artery disease risk factors by menopausal status: A population based study among Iranian women (KERCADRStudy). Arya Atherosclerosis 2013;9(6):332-336.

 

 

  1. RahimiN, Gozashti MH, Najafipour H, Shokoohi M, Marefati H. Potential Effect of Opium Consumption on Controlling Diabetes and Some Cardiovascular Risk Factors in Diabetic Patients. Addict Health 2013;5(3-4):1-6.

 

  1. Najafipour H, MalekMohammadi T, Foad Rahim, Haghdoost AA, ShadkamM,  Afshari M. Association of oral health as a cardiovascular disease risk factor (CVDRF) with other CVDRFs: Results from a community based study on 5900 adult subjects.ISRN Cardiology 2013June:1-6.

 

 

  1. Shahouzehi B, Shokouhi M, Najafipour H. The Effect of opium addiction on serum Levels of Adiponectinand Leptin in male subjects:a case control study from KERCADRS. EXCLI Journal 2013;12:916-923.

 

  1. Yousefzadeh Gh,Shokoohi M, Yeganeh M, Najafipour H.Role of gamma-glutamyl transferase (GGT) in diagnosis of impaired glucose tolerance and metabolic syndrome: A prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetes & Metabolic Syndrome: Clinical Research & Reviews

       2012;6:(190–194).

 

  1. SamarehFekri M, Shokoohi M, Gozashti MH, Esmailian S, Jamshidian N, Shadkam-Farokhi M, Lashkarizadeh MR MalekpourAfshar R. Association between Anti-Thyroid Peroxidase Antibody and Asthma in Women.Iran J Allergy Asthma Immunol 2012;11(3): 241- 245.

 

  1. Foroozanfar Z, Ebrahimi H, Khanjani N, Bahrampour A, Najafipour H. Comparing indices of median nerve among diabetic patients with or without metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017;11(S2):S669-S673.

 

  1. Najafipour H, Mirzazadeh A, HaghdoostAA, Shadkam M, Afshari M, et al.Coronary Artery Disease Risk Factors in an urban and pri-urban setting (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health 2012;41(9):86-92.

 

 

فاز دوم  32 مقاله

عناوین مقالات:

 

  1. Yeganeh-Hajahmadi M, Mehrabani M, Esmaili M, Farokhi MS, Sanjari M. Protamine as a barrier against the angiogenic effect of insulin: a possible role of apelin. Sci Rep. 2023 Oct 12;13(1):17267.

 

  1. Jafari, A., Najafipour, H., Shadkam, M. et al. Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS). Lipids Health Dis 22, 169 (2023).

 

  1. Najafzadeh MJ, Baniasad A, Shahabinejad R, Mashrooteh M, Najafipour H, Gozashti MH.Investigating the relationship between haematological parameters and metabolic syndrome: A population-based study. Endocrinol Diab Metab. 2023.

 

  1. Mahmoodzadeh S, Jahani Y, Najafipour H, Sanjari M, Shadkam-Farokhi M, et al. External Validation of Finnish Diabetes Risk Score and Australian Diabetes Risk Assessment Tool Prediction Models to Identify People with Undiagnosed Type 2 Diabetes: A Cross-sectional Study in Iran. Int J Endocrinol Metab. 2022;20(4):e127114.

 

  1. Zamaninasab Z, Najafipour H, Mirzaee M, Bahrampour A. A Cluster-wise Linear Regression Model to Investigate the Effect of Demographical and Clinical Variables on the Average Depression Score. Med J Islam Repub Iran. 2022 (8 Oct);36:116.

 

  1. Yazdi F, Baghaei MH, Baniasad A, Naghibzadeh-Tahami A, Najafipour H, Gozashti MH. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome.Endocrinol Diab Metab. 2022;5:e00311.

 

  1. Alemeh Peydayesh, Hamid Najafipour, Zohreh Rahaei, Mitra Shadkam-Farokhi, & Sara Jambarsang. (2022). Risk Factors of Myocardial Infarction in the Elderly People: Results of Kerman Coronary Artery Disease Risk Factors Cohort Study (KERCADRS). Journal of Pharmaceutical Negative Results, 1562–1568.

 

  1. Amini F, Khajevand Khoshli A, Asadi J, Bahar A, Najafipour H, Mirzazadeh A. Obesity Mediates the Effect of Past and Current Mental Health on Diabetes Treatment Outcomes. Iran J Public Health. 2022;51(11):2608-2618.

 

  1. Najafipour H, Mahdavi A , Kordestani Z, Zamaninasab Z, Shadkam Farokhi M, Shamsadini A, Azizi E. The prevalence and 5-year incidence rate of cigarette smoking and water-pipe tobacco smoking and their associated factors among 15 to 80 years old urban population in southeast Iran: results from KERCADR study. Addict Health. 2022;14(3):205-213.

 

  1. Yazdi F, Shakibi MR, Baniasad A, et al. Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population-based study. Endocrinol Diab Metab. 2022;00:e387.

 

  1. Najafipour H, Sabahi A, khoramipour kayvan, Shojaei Shahrokhabad M, Banivaheb G, Shadkam M, Mirzazadeh A. Prevalence, Incidence and Health Impacts of Sleep Disorders on Coronary Artery Disease Risk Factors: Results of a Community-Based Cohort Study (KERCADRS). Iran J Psychiatry. 2022;17(3):247-256.

 

  1. Mahmoodi MR, Najafipour H (2022) Association of C-peptide and lipoprotein(a) as two predictors with cardiometabolic biomarkers in patients with type 2 diabetes in KERCADR population-based study. PLoS ONE 17(5): e0268927

 

  1. Mahmoodi MR, Najafipour H. Associations between serum vitamin D3, atherogenic indices of plasma and cardiometabolic biomarkers among patients with diabetes in the KERCADR study. BMC Endocr Disord. 2022 May 12;22(1):126.

 

  1. Jangipour Afshar P, Najafipour H, Shadkam Farokhi M, Shahesmaeili A. How Much Excess Body Weight, Blood Pressure, Triglyceride, or Age Can Double the Likelihood of Diabetes Type 2?. Iran J Public Health. 2022;51(4):939-945.

 

  1. Najafipour H, Masoumi M, Amirzadeh R, Rostamzadeh F, Foad R, Shadkam Farrokhi M. Trends in the Prevalence and Incidence of Opium Abuse and its Association with Coronary Artery Risk Factors in Adult Population in Iran: Findings from Kerman Coronary Artery Disease Risk Factors Study. Iran J Med Sci. doi: 10.30476/IJMS.2021.89898.2065.

 

  1. Najafipour H, Farjami M, Sanjari M, Amirzadeh R, Shadkam Farokhi M and Mirzazadeh A (2021) Prevalence and Incidence Rate of Diabetes, Pre-diabetes, Uncontrolled Diabetes, and Their Predictors in the Adult Population in Southeastern Iran: Findings From KERCADR Study. Front. Public Health 9:611652.

 

  1. Najafipour H, Abdollahi F, Khatibi M, Amirzadeh R. Dietary status with demographic and anthropometric variables and some health affecting risk factors in people of Southeastern Iran: A population-based study (KERCADRS). Caspian J Intern Med 2021; 12(4): 551-561.

 

  1. Yazdi F, Baghaei MH, Baniasad A, Naghibzadeh-Tahami A, Najafipour H, Gozashti MH. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diab Metab. 2021;00:e311.

 

  1. Yeganeh-Hajahmadi, M., Najafipour, H., Rostamzadeh, F. et al. Klotho and SIRT1 changes from pre-diabetes to diabetes and pre-hypertension to hypertension. Diabetol Metab Syndr 13, 115 (2021)

 

  1. Najafipour H, Yousefzadeh G, Baneshi MR, Ahmadi Gohari M, Shahouzehi B, Farokhi MS, et al. Prevalence and 5‑year incidence rate of dyslipidemia and its association with other coronary artery disease risk factors in Iran: Results of the Kerman coronary artery disease risk factors study (Phase 2). J Res Med Sci 2021;26:99.

 

  1. Najafipour H; Bagheri M; Saberi S; Farokhi M; Amirzadeh R; Mirzazadeh A. Epidemiological update on prevalence and incidence of overweight and obesity in adults in the south-east of the Islamic Republic of Iran: findings from the Kerman Coronary Artery Diseases Risk FActors Study (KERCADRS). East Mediterr Health J. 2021;27(9):874-883.

 

  1. Enhesari A, Khatami M, Gozashti M H, Safi Z, Khatami M. A study on the relationship between serum uric acid and the thickness of intima-mediated carotid. J Adv Pharm Educ Res. 2021;11(3):83- 7

 

  1. Najafipour H, Sadeghi M, Kordestani Z, Naghibzadeh Tahamy A, Ghavipisheh M, Shadkam Farokhi M. The Prevalence of Musculoskeletal Pain Syndrome in 15-80 years old Population of Kerman: The Role of Smart Phone Use and its Related Factors. Journal of Kerman University of Medical Sciences 2021; 28(4): 358-366

 

  1. Nekouei AH, Kakooei S, Najafipour H, Kakoei S. Oral Health Determinants among Opium Users in Kerman, Iran. Addict Health 2021; 13(3): ?-?.

 

  1. Najafipour H, Shahrokhabadi MS, Banivaheb G, et al. Trends in the prevalence and incidence of anxiety and depressive symptoms in Iran: findings from KERCADRS. Fam Med Com Health 2021;9:e000937

 

  1. Kakoei Sh, Nekouei AH, Kakooei S, Najafipour H. The effect of demographic characteristics on the relationship between smoking and dry mouth in Iran:  a cross-sectional, case-control study. Epidemiol Health 2021:1-6

 

  1.  Daneshpajooh A, Naghibzadeh‐Tahami A, Najafipour H, Mirzaei M. Prevalence and risk factors of urinary incontinence among Iranian women. Neurourology and Urodynamics. 2021;1–11.

 

  1. Najafipour, H., Nasri, H.R., Rostamzadeh, F. et al. Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS). J Hum Hypertens (2020)

 

 

  1. Najafipour H, Kahnooji M,  Baneshi MR, Yeganeh M, Ahmadi Gohari M, Shadkam Farokhi M, Mirzazadeh A.The Prevalence and 5-Year Incidence Rate of Low Physical Activity in 10,000 Urban Population in South East of Iran: Relationship With Other Cardiovascular Risk Factors. Journal of Physical Activity and Health 2020;17(4):435-442.

 

  1. Asadikaram G, Ram M,Izadi A, et al. The study of the serum level of IL‐4,TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension.J Cell Biochem. 2018;1‐11.

 

 

  1. Asadikaram G, Akbari H, Safi Z, Shadkam M, Khaksari M, Shahrokhi N, Najafipour H, Sanjari M, Arababadi MK. Downregulation of IL-22 can be considered as a risk factor for onset of type 2 diabetes. J Cell Biochem 2018 Jun;119(11).

 

  1. Najafipour H, Sadeghigoghari M, Kordestani Z, Naghibzadeh Tahami A, Ghavipisheh M. et al. Prevalence of the Musculoskeletal Pain Syndrome and Its Associated Factors in People Between 15 and 80 Years in Kerman: A Population-based Study on 1700 Individuals, Iran Red Crescent Med J 2017;19(4):e45084.

 

 

 

فاز سوم 2 مقاله

عناوین مقالات:

 

 

  1. Rostamzadeh F, Najafipour H, Yazdani R, Nakhaei S, Alinaghi Langari A. Changes in serum levels of apelin and nitric oxide in hospitalized patients with COVID-19: association with hypertension, diabetes, obesity, and severity of disease. Eur J Med Res. 2022 Nov 9;27(1):243.

 

  1. Najafipour H, Shojaei Shahrokhabadi M, Nasri HR, Movali E, Shadkam M. Effects of Quarantine due to the COVID-19 on Sleep Time, Anxiety, and Physical Activity in Adult Population: A Longitudinal Study in Kerman, Southeastern Iran. Journal of Kerman University of Medical Sciences 2021; 28(3): 219-229.

 

 

 

پمفلت های آموزشی

1 -  بیماری فشارخون  2-  بيماری رگهای قلب  3-  خطرات افزایش چربی های خون  4-  علائم حمله قلبی

5-  دیابت  6 -  نکاتی درمورد تزریق انسولین 7-  دیابت حاملگی 8-  پای دیابتی 9-  توصیه های ورزشی به افراد دیابتی 10-  خواب بدون خروپف

 

پمفلت های فوق در وبسایت مرکز به آدرس

https://kprc.kmu.ac.ir/fa/page/53074/%D9%85%D8%AD%D8%AA%D9%88%D8%A7%DB%8C-%D8%A2%D9%85%D9%88%D8%B2%D8%B4%DB%8C

قابل دسترسی است.

 

 

 

 

نظرسنجـــی
نظر شما درخصوص خدمات ارائه شده در معاونت تحقیقات و فناوری چیست
عالی
42%
 
متوسط
23%
 
ضعیف
33%
 
ارتباط با ما

 

 

 کرمان،چهارراه سمیه (طهماسب آباد) ابتدای خیابان ابن سینا،معاونت تحقیقات و فناوری 
تلفن

03432263719

03432263790

03432263821

03432227976

03432263787
فاکس 03432263857
 

 

امروز: 196
بازدید کل: 891,218
آخرین بروزرسانی: چهار شنبه 6 اسفند 1404
© Copyright ©2026 kmu.ac.ir All Rights Reserved. Powered by targan.ir Version 5.6.163®
کلیه حقوق این سامانه متعلق به مدیریت آمار و فناوری اطلاعات دانشگاه علوم پزشکی کرمان می باشد.